Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
35 hedge funds and large institutions have $53.8M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
6% more funds holding
Funds holding: 33 → 35 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $62M → $53.8M (-$8.23M)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $193K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.55M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$329K |
| 3 |
Renaissance Technologies
New York
|
+$150K |
| 4 |
JP Morgan Chase
New York
|
+$142K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$11.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.97M |
| 2 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$1.07M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$911K |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$471K |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$365K |
CORV Hedge Fund Activity: Q4 2016 in Review
35 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q4 2016, worth a combined $53.8M — down 13% from $62M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CORV positions and 2 closed out — a net gain of 2 holders — while 8 added to existing stakes and 12 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $3.55M. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.97M sold.
- 35 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q4 2016, up from 33 in Q3 2016.
- Funds reported $53.8M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q4 2016, down 13% quarter-over-quarter.
- 4 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q4 2016 and 2 closed out, a net change of +2 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q4 2016 was Stonepine Capital Management, an estimated $3.55M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q4 2016 was Fidelity Investments, an estimated $1.97M sold.
Based on aggregated 13F filings for Q4 2016.